Literature DB >> 15857882

From conference abstract to full paper: differences between data presented in conferences and journals.

Evangelos S Rosmarakis1, Elpidoforos S Soteriades, Paschalis I Vergidis, Sofia K Kasiakou, Matthew E Falagas.   

Abstract

BACKGROUND: We studied the type and frequency of differences between data presented in conference abstracts and subsequent published papers in the fields of infectious diseases and microbiology.
METHODS: We reviewed all abstracts from the first session of 7 of 15 major research categories presented in the 1999 and 2000 Interscience Conference on Antimicrobial Agents and Chemotherapy. For each selected pair of abstract and related published paper, two independent investigators performed a detailed data comparison.
RESULTS: From 190 abstracts reviewed, 68 (36%) were subsequently published as full papers by March 2004. Fifty-two pairs referred to the same study population and period. Differences were found in 30 of 51 pairs, which were further analyzed (point estimate=59%, 95% C.I.: 45-73%). The identified differences were related to both the aims and conclusions of the study (3/30), the study conclusions only (2/30), numbers and/or rates of the studied patients (10/30), numbers or rates of microbiological isolates (9/30), MIC values or K(i) values (5/30), other pharmacological properties of antibiotics (2/30), odds ratio (1/30), and duration of observation (1/30). Some differences were considered major. In bivariable associations, time to publication (from presentation in the conference to publication of the full paper) was associated with identifiable differences between the conference abstract and the full paper (OR=1.76, 95% CI 0.95-3.24/year of delay, P=0.07).
CONCLUSIONS: It is reassuring that although we identified several reportable differences, only a very small proportion of studies exhibited differences in their aims and/or conclusions. Researchers may benefit from the above findings in improving the accuracy of presented data.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857882     DOI: 10.1096/fj.04-3140lfe

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.

Authors:  Konstantinos Z Vardakas; Michael N Mavros; Nikolaos Roussos; Matthew E Falagas
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

2.  Archiving "event knowledge": bringing "dark data" to light.

Authors:  Joshua Illig
Journal:  J Med Libr Assoc       Date:  2008-07

3.  Publication patterns of cancer cost-effectiveness studies presented at major conferences.

Authors:  K K Chan; E Siu; L Mozessohn; M C Cheung
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

Review 4.  Antimicrobials as an adjunct to pilonidal disease surgery: a systematic review of the literature.

Authors:  M N Mavros; P K Mitsikostas; V G Alexiou; G Peppas; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-05       Impact factor: 3.267

5.  Current findings from research on structured abstracts: an update.

Authors:  James Hartley
Journal:  J Med Libr Assoc       Date:  2014-07

Review 6.  Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.

Authors:  Verena S Hoffmann; Joerg Hasford; Michael Deininger; Jorge Cortes; Michele Baccarani; Rüdiger Hehlmann
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-08       Impact factor: 4.553

7.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials.

Authors:  Konstantinos Z Vardakas; Ilias I Siempos; Alexandros Grammatikos; Zoe Athanassa; Ioanna P Korbila; Matthew E Falagas
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

10.  Peer review in open access scientific journals.

Authors:  Matthew E Falagas
Journal:  Open Med       Date:  2007-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.